Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of January 2026
John Fourier @John Fourier
Gold member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$7,904,023talents

Virtual portfolio value:

$4,978,489talents

Net overall return per annum:

19.41%

AYA current rank order:

#18

Asset investment philosophy:
John Fourier trades U.S. stocks with the top #276 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 129,826 +793.33% $154,493
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
VATE INNOVATE Corp. Common Stock $0.53 $4.14 36,743 +681.13% $132,642
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 857 +601.88% $95,890
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 9,925 +2,108.33% $75,331
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,441 +590.22% $39,123
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 951 +589.24% $39,058
SQ Block Inc. Class A Common Stock $14.50 $99.54 457 +586.48% $38,863
FIVN Five9 Inc. Common Stock $16.31 $110.10 406 +575.05% $38,079
Sum $884,145

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$ZIM

Blog+More

Gold prices surge above $1400 per ounce amid global trade tension and economic policy uncertainty.

Charlene Vos

2019-07-17 12:37:00 Wednesday ET

Gold prices surge above $1400 per ounce amid global trade tension and economic policy uncertainty.

Gold prices surge above $1400 per ounce amid global trade tension and economic policy uncertainty. Both European Central Bank and Bank of Japan may consider

+See More

Top money managers George Soros and Warren Buffett reveal their current stock and bond positions.

Dan Rochefort

2018-05-10 07:37:00 Thursday ET

Top money managers George Soros and Warren Buffett reveal their current stock and bond positions.

Top money managers George Soros and Warren Buffett reveal their current stock and bond positions in their recent corporate disclosures as of mid-2018. Georg

+See More

The bank-credit-card model and fintech platforms have adapted well to the recent digitization of cashless finance.

Daphne Basel

2023-11-30 08:29:00 Thursday ET

The bank-credit-card model and fintech platforms have adapted well to the recent digitization of cashless finance.

In addition to the OECD bank-credit-card model and Chinese online payment platforms, the open-payments gateways of UPI in India and Pix in Brazil have adapt

+See More

Admitting China to the WTO seems ineffective in imparting economic freedom and democracy to the communist regime.

Dan Rochefort

2018-07-27 10:35:00 Friday ET

Admitting China to the WTO seems ineffective in imparting economic freedom and democracy to the communist regime.

Admitting China to the World Trade Organization (WTO) and other international activities seems ineffective in imparting economic freedom and democracy to th

+See More

Facebook, Twitter, and Google executives explain the scope of Russian interference in the U.S. 2016 presidential election.

Apple Boston

2017-09-19 05:34:00 Tuesday ET

Facebook, Twitter, and Google executives explain the scope of Russian interference in the U.S. 2016 presidential election.

Facebook, Twitter, and Google executives head before the Senate Judiciary Committee to explain the scope of Russian interference in the U.S. presidential el

+See More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More